Tesaro, Inc. Announces Proposed Public Offering Of Common Stock

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WALTHAM, Mass., Jan. 28, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that it has commenced an underwritten public offering of $100 million of its common stock. In connection with this offering, TESARO plans to grant the underwriters an option to purchase up to an additional $15 million of its common stock to cover over-allotments. Citigroup, Deutsche Bank Securities and Leerink Partners are acting as joint book-running managers for the offering, with BMO Capital Markets and Baird acting as co-managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC